Olema Pharmaceuticals (OLMA) Institutional Ownership $5.71 -0.03 (-0.52%) As of 10:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Olema Pharmaceuticals (NASDAQ:OLMA)CurrentInstitutional OwnershipPercentage91.78%Number ofInstitutional Buyers(last 12 months)97TotalInstitutional Inflows(last 12 months)$147.44MNumber ofInstitutional Sellers(last 12 months)40TotalInstitutional Outflows(last 12 months)$50.12M Get OLMA Insider Trade Alerts Want to know when executives and insiders are buying or selling Olema Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data OLMA Institutional Buying and Selling by Quarter Olema Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/26/2025 Thrivent Financial for Lutherans72,455$308K0.0%N/A0.106% 8/15/2025 BNP Paribas Financial Markets6,585$28K0.0%-98.2%0.010% 8/15/2025 Bridgeway Capital Management LLC50,000$213K0.0%N/A0.073% 8/15/2025 Birchview Capital LP134,000$571K0.6%N/A0.195% 8/15/2025 Bank of America Corp DE799,502$3.41M0.0%-12.0%1.165% 8/15/2025 Ameriprise Financial Inc.1,172,863$5.00M0.0%+193.4%1.709% 8/14/2025 MPM Bioimpact LLC2,378,762$10.13M1.8%-18.8%3.466% 8/14/2025 PDT Partners LLC28,337$121K0.0%-61.9%0.041% 8/14/2025 The Manufacturers Life Insurance Company 22,442$96K0.0%+46.7%0.033% 8/14/2025 HighVista Strategies LLC278,430$1.19M0.4%+31.2%0.407% Get the Latest News and Ratings for OLMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Olema Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/14/2025 Diadema Partners LP253,657$1.08M0.3%+153.7%0.371% 8/13/2025 Affinity Asset Advisors LLC250,000$1.07M0.1%-23.1%0.365% 8/13/2025 Marshall Wace LLP12,800$55K0.0%-96.0%0.019% 8/13/2025 Invesco Ltd.79,929$340K0.0%+57.3%0.117% 8/13/2025 Schroder Investment Management Group618,184$2.63M0.0%+16.0%0.904% 8/12/2025 XTX Topco Ltd80,414$343K0.0%N/A0.118% 8/12/2025 Ameritas Investment Partners Inc.6,080$26K0.0%+55.4%0.009% 8/12/2025 Titleist Asset Management LLC15,000$64K0.0%N/A0.022% 8/12/2025 American Century Companies Inc.12,756$54K0.0%N/A0.019% 8/12/2025 Rhumbline Advisers86,027$366K0.0%+48.2%0.126% 8/12/2025 JPMorgan Chase & Co.32,479$138K0.0%-88.7%0.047% 8/11/2025 Persistent Asset Partners Ltd58,333$248K0.2%+153.8%0.085% 8/8/2025 Intech Investment Management LLC38,609$164K0.0%+58.8%0.056% 8/8/2025 Creative Planning19,521$83K0.0%N/A0.029% 8/8/2025 Police & Firemen s Retirement System of New Jersey14,195$60K0.0%+76.2%0.021% 8/8/2025 Geode Capital Management LLC1,326,123$5.65M0.0%+22.4%1.938% 8/7/2025 ProShare Advisors LLC14,766$63K0.0%+21.1%0.022% 8/5/2025 Pier Capital LLC771,072$3.29M0.5%-5.7%1.127% 7/30/2025 FNY Investment Advisers LLC10,000$42K0.0%+100.0%0.015% 7/11/2025 Farther Finance Advisors LLC6,839$29K0.0%+602.9%0.010% 6/27/2025 Goldman Sachs Group Inc.741,329$2.79M0.0%+93.6%1.083% 5/19/2025 Jane Street Group LLC138,552$521K0.0%+216.8%0.203% 5/16/2025 Woodline Partners LP1,477,907$5.56M0.0%+8.9%2.162% 5/16/2025 Goldman Sachs Group Inc.741,329$2.79M0.0%+93.6%1.084% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.23,932$90K0.0%-8.7%0.035% 5/16/2025 BVF Inc. IL5,295,893$19.91M0.8%-7.3%7.747% 5/16/2025 Bain Capital Life Sciences Investors LLC6,843,954$25.73M3.8%-8.4%10.011% 5/16/2025 AQR Capital Management LLC45,661$172K0.0%N/A0.067% 5/15/2025 MPM Bioimpact LLC2,930,446$11.02M1.9%+0.6%4.287% 5/15/2025 PDT Partners LLC74,299$279K0.0%N/A0.109% When the levee breaks (Ad)The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point. In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.Click here to watch the urgent broadcast and get ahead of what’s coming.5/15/2025 Cubist Systematic Strategies LLC93,669$352K0.0%+260.4%0.137% 5/15/2025 Alpine Global Management LLC13,874$52K0.0%N/A0.020% 5/15/2025 Quarry LP12,000$45K0.0%N/A0.018% 5/15/2025 Paradigm Biocapital Advisors LP6,741,172$25.35M1.2%-7.7%9.861% 5/14/2025 Affinity Asset Advisors LLC325,000$1.22M0.1%N/A0.475% 5/14/2025 MetLife Investment Management LLC17,675$66K0.0%-25.4%0.026% 5/14/2025 Walleye Capital LLC87,705$330K0.0%+30.9%0.128% 5/14/2025 Portland Investment Counsel Inc.50,000$188K0.1%+100.0%0.073% 5/14/2025 Candriam S.C.A.850,517$3.20M0.0%-45.2%1.244% 5/14/2025 Hsbc Holdings PLC15,698$58K0.0%+56.9%0.023% 5/14/2025 Wellington Management Group LLP1,473,679$5.54M0.0%-3.4%2.156% 5/13/2025 Brooklyn Investment Group18,915$71K0.0%N/A0.028% 5/13/2025 Persistent Asset Partners Ltd22,988$86K0.1%N/A0.034% 5/12/2025 Nuveen LLC344,296$1.30M0.0%N/A0.504% 5/12/2025 Invesco Ltd.50,810$191K0.0%+208.9%0.074% 5/9/2025 Deutsche Bank AG54,329$204K0.0%+38.1%0.079% 5/9/2025 Charles Schwab Investment Management Inc.349,023$1.31M0.0%+4.8%0.511% 5/7/2025 Corton Capital Inc.21,741$82K0.3%+25.6%0.032% 5/6/2025 Y Intercept Hong Kong Ltd10,882$41K0.0%-42.7%0.016% 4/30/2025 Alps Advisors Inc.50,484$190K0.0%+9.0%0.074% 4/30/2025China Universal Asset Management Co. Ltd.14,892$56K0.0%+22.6%0.022% 4/29/2025 Bank of New York Mellon Corp131,994$496K0.0%+2.6%0.193% 4/10/2025 Hennion & Walsh Asset Management Inc.242,486$912K0.0%+14.2%0.355% 3/24/2025 Wellington Management Group LLP1,525,484$8.84M0.0%+52.1%2.662% 2/25/2025 Polar Asset Management Partners Inc.20,400$119K0.0%N/A0.036% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC93,979$548K0.0%+23.7%0.164% 2/17/2025 Woodline Partners LP1,357,479$7.91M0.1%+0.2%2.369% 2/17/2025 Squarepoint Ops LLC48,829$285K0.0%+205.8%0.085% 2/17/2025 Two Sigma Investments LP72,877$425K0.0%-27.2%0.127% 2/17/2025 Two Sigma Advisers LP89,000$519K0.0%-12.1%0.155% 2/17/2025 Rafferty Asset Management LLC81,424$475K0.0%-10.0%0.142% 2/17/2025 Point72 Asset Management L.P.3,670,826$21.40M0.0%-0.4%6.406% 2/17/2025 Polar Asset Management Partners Inc.20,400$119K0.0%N/A0.036% 2/17/2025 ProShare Advisors LLC14,226$83K0.0%+30.2%0.025% 2/17/2025 MPM Bioimpact LLC2,912,550$16.98M2.4%+8.7%5.083% 2/17/2025 Paradigm Biocapital Advisors LP7,304,970$42.59M1.5%+32.7%12.749% 2/17/2025 Millennium Management LLC979,219$5.71M0.0%+1,154.4%1.709% 2/17/2025 Lightspeed Management Company L.L.C.1,930,894$11.26M3.1%N/A3.370% 2/17/2025 J. Goldman & Co LP13,500$79K0.0%-60.0%0.024% 2/17/2025 Deutsche Bank AG39,331$229K0.0%+45.0%0.069% 2/17/2025 D. E. Shaw & Co. Inc.12,445$73K0.0%-51.4%0.022% 2/17/2025 Driehaus Capital Management LLC220,264$1.28M0.0%N/A0.384% 2/17/2025 Deep Track Capital LP3,442,833$20.07M0.7%-13.9%6.008% 2/17/2025 Cubist Systematic Strategies LLC25,987$152K0.0%N/A0.045% 2/17/2025 BVF Inc. IL5,715,893$33.32M1.1%-37.4%9.975% 2/17/2025 Balyasny Asset Management L.P.1,127,589$6.57M0.0%+59.0%1.968% 2/17/2025 Bank of America Corp DE865,339$5.05M0.0%+110.6%1.510% 2/17/2025 BNP Paribas Financial Markets193,748$1.13M0.0%N/A0.338% 2/17/2025 Ameriprise Financial Inc.449,698$2.62M0.0%-2.9%0.785% 2/14/2025 Boxer Capital Management LLC650,000$3.79M0.3%N/A1.134% When the levee breaks (Ad)The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point. In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.Click here to watch the urgent broadcast and get ahead of what’s coming.2/14/2025 Jane Street Group LLC43,737$255K0.0%-44.7%0.076% 2/14/2025 Schonfeld Strategic Advisors LLC505,400$2.95M0.0%+9.4%0.882% 2/14/2025 Northern Trust Corp423,787$2.47M0.0%+8.7%0.740% 2/14/2025 Aquatic Capital Management LLC31,565$184K0.0%N/A0.055% 2/14/2025 Boothbay Fund Management LLC31,226$182K0.0%+10.8%0.054% 2/14/2025 Susquehanna Fundamental Investments LLC10,976$64K0.0%N/A0.019% 2/14/2025 Virtus ETF Advisers LLC10,579$62K0.0%+43.1%0.018% 2/14/2025 Voya Investment Management LLC12,523$73K0.0%-76.0%0.022% 2/14/2025 Adage Capital Partners GP L.L.C.365,198$2.13M0.0%-8.7%0.637% 2/14/2025 Syon Capital LLC13,151$77K0.0%N/A0.023% (Data available from 1/1/2016 forward) OLMA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OLMA shares? During the previous two years, 145 institutional investors and hedge funds held shares of Olema Pharmaceuticals. The most heavily invested institutionals were Logos Global Management LP ($34.72M), Bain Capital Life Sciences Investors LLC ($25.73M), Paradigm Biocapital Advisors LP ($25.35M), State Street Corp ($23.52M), Vivo Capital LLC ($23.14M), Point72 Asset Management L.P. ($21.40M), and Deep Track Capital LP ($20.07M).Learn more on Olema Pharmaceuticals' institutional investors. What percentage of Olema Pharmaceuticals' stock is owned by institutional investors? 91.78% of Olema Pharmaceuticals' stock is owned by institutional investors. Learn more on OLMA's institutional investor holdings. Which institutional investors have been buying Olema Pharmaceuticals' stock? Of the 122 institutional investors that purchased Olema Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Bain Capital Life Sciences Investors LLC ($7.47M), Point72 Asset Management L.P. ($3.69M), Lightspeed Management Company L.L.C. ($1.93M), Paradigm Biocapital Advisors LP ($1.80M), Avoro Capital Advisors LLC ($1.65M), MPM Bioimpact LLC ($1.65M), and Wellington Management Group LLP ($1.18M). How much institutional buying is happening at Olema Pharmaceuticals? Institutional investors have bought a total of 24,875,010 shares in the last 24 months. This purchase volume represents approximately $147.44M in transactions. Which of Olema Pharmaceuticals' major shareholders have been selling company stock? Of the 40 institutional investors that sold Olema Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: BVF Inc. IL ($3.84M), Victory Capital Management Inc. ($758.41K), Candriam S.C.A. ($701.05K), Bain Capital Life Sciences Investors LLC ($626.26K), Paradigm Biocapital Advisors LP ($563.80K), Deep Track Capital LP ($557.17K), and MPM Bioimpact LLC ($551.68K). How much institutional selling is happening at Olema Pharmaceuticals? Institutional investors have sold a total of 9,681,238 shares in the last 24 months. This volume of shares sold represents approximately $50.12M in transactions. Related Companies JANX Major Shareholders EWTX Major Shareholders ARDX Major Shareholders HROW Major Shareholders SPRY Major Shareholders SDGR Major Shareholders AMPH Major Shareholders VERA Major Shareholders ABCL Major Shareholders ETNB Major Shareholders This page (NASDAQ:OLMA) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredThis strange black card is showing up across America"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Olema Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Olema Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access